Crispr-based Ocular Therapy
CRISPR-Based Ocular Therapy is a gene-editing intervention that employs CRISPR-Cas systems to precisely modify genetic sequences within ocular tissues for the treatment of inherited or acquired eye disorders.
32
Publications
3.1K
Citations
251
Authors
83
Institutions
Publications per year
2017–2026
28
Parents
32
Gene therapy restores vision in a canine model of childhood blindness
Gregory M. Acland, Jharna Ray, Qí Zhāng et al. · Nature Genetics · 2001 · 1.2K citations
Serena Giannelli, Mirko Luoni, Valerio Castoldi et al. · Human Molecular Genetics · 2017 · 130 citations · Full text
1–5 of 32
251
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 251
83
University College London
London, United Kingdom
4 h-index
8 publications
482 citations

Aarhus University
Aarhus, Denmark
3 h-index
12 publications
618 citations
University of Iowa
Iowa City, United States
3 h-index
7 publications
128 citations

Aarhus University Hospital
Aarhus, Denmark
3 h-index
5 publications
231 citations
University of Florida
Gainesville, United States
2 h-index
2 publications
1.2K citations

Jinan University
Guangzhou, China
2 h-index
4 publications
96 citations
Smith-Kettlewell Eye Research Institute
San Francisco, United States
2 h-index
8 publications
140 citations

Moorfields Eye Hospital NHS Foundation Trust
London, United Kingdom
2 h-index
5 publications
306 citations
1–8 of 83
4 publications · 105 citations
4
h-index
Book series · 2 publications · 31 citations
2
h-index
2 publications · 127 citations
2
h-index
IOVS · 2 publications · 38 citations
2
h-index
2 publications · 41 citations
2
h-index
1–5